A model for prediction of recurrence of non-small cell lung cancer based on clinical data and CT imaging characteristics

被引:0
|
作者
Yu, Xinjie [1 ]
Yang, Dengfa [2 ]
Xu, Gang [3 ]
Tian, Fengjuan [4 ]
Shi, Hengfeng [5 ]
Xie, Zongyu [6 ]
Cao, Zhenyu [1 ]
Wang, Jian [1 ]
机构
[1] Zhejiang Chinese Med Univ, Tongde Hosp, Tongde Hosp Zhejiang Prov, Dept Radiol, Hangzhou, Peoples R China
[2] Taizhou Municipal Hosp, Dept Radiol, Taizhou, Zhejiang, Peoples R China
[3] Xin Hua Hosp Huainan, Dept Radiol, Huainan, Anhui, Peoples R China
[4] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Radiol, Hangzhou, Zhejiang, Peoples R China
[5] Anqing Municipal Hosp, Dept Radiol, Anqing, Anhui, Peoples R China
[6] Bengbu Med Coll, Affiliated Hosp 1, Dept Radiol, Bengbu, Anhui, Peoples R China
关键词
Non-small cell lung cancer; Recurrence; Computed tomography; Nomogram; GROUND-GLASS OPACITY; STAGE-I; PROGNOSTIC-SIGNIFICANCE; DISTANT RECURRENCE; 8TH EDITION; IMPACT; CA125; NSE;
D O I
10.1016/j.clinimag.2025.110416
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives: To establish a model for prediction of recurrence of non-small cell lung cancer (NSCLC) based on clinical data and computed tomography (CT) imaging characteristics. Methods: A total of 695 patients with surgically resected NSCLC confirmed by pathology at three centers were retrospectively investigated. 626 patients from center 1 were randomly divided into two sets in a ratio of 7:3 (training set, n = 438; testing set, n = 188), 69 patients from center 2 and 3 were assigned in the external validation set. Univariate and binary logistic regression analyses of clinical and CT imaging features determined the independent risk factors used to construct the model. The receiver-operating characteristic curve nomogram and decision curves analysis were used to evaluate the predictive ability of the model. Results: The mean patient age was 63.3 +/- 10.1 years, and 44.7 % (311/695) were male. The univariate and binary logistic regression analyses identified four independent risk factors (age, tumor markers, consolidation/ tumor ratio, and pleural effusion), which were used to construct the prediction model. In the training set, the model had an area under the curve of 0.857, an accuracy of 71.7 %, a sensitivity of 88.1 %, and a specificity of 70.0 %; in the testing set, the respective values were 0.867, 75.5 %, 94.4 %, and 73.5 %; in the external validation set, the respective values were 0.852, 79.7 %, 83.3 %, 78.9 %. Conclusion: A prediction model based on clinical data and CT imaging characteristics showed excellent efficiency in prediction of recurrence of NSCLC. Clinical use of this model could be useful for selection of appropriate treatment options.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Clinical Characteristics Of Non-Small Cell Lung Cancer As A Second Primary Malignancy
    Duma, N.
    Kang, M.
    Abu-Ihweij, K.
    Gandhi, A.
    Choudhary, M.
    Harper, H.
    Gutierrez, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [32] Clinical characteristics of miliary pulmonary metastases in non-small cell lung cancer
    Choi, Hanmil
    Im, Yunjoo
    Jeong, Byeong-Ho
    Lee, Kyungjong
    Kim, Hojoong
    Um, Sang-Won
    THORACIC CANCER, 2023, 14 (22) : 2168 - 2176
  • [33] Clinical Characteristics of 274 Non-Small Cell Lung Cancer Patients in China
    Chen, Yan
    Han, Sheng
    Zheng, Min-Juan
    Xue, Yan
    Liu, Wen-Chao
    ONKOLOGIE, 2013, 36 (05): : 248 - 254
  • [34] CLINICAL CHARACTERISTICS OF ACQUIRED RESISTANCE TO GEFITINIB IN NON-SMALL CELL LUNG CANCER
    Lee, Kye Young
    Kim, Hee Joung
    Kim, Young-Chul
    Shin, Kyeong-Cheol
    Lee, Jae Chol
    Ryu, Jeong Seon
    Jang, Seung Hoon
    Kim, Sun Young
    Jang, Tae Won
    RESPIROLOGY, 2010, 15 : 37 - 37
  • [35] Tissue polypeptide specific antigen for early prediction of non-small cell lung cancer recurrence
    Chen, CY
    Kao, CH
    Hsieh, YH
    Gu, CJ
    ONCOLOGY REPORTS, 1997, 4 (06) : 1391 - 1394
  • [36] Clinical Characteristics of Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer
    Lee, Kye Young
    Kim, Hee Joung
    Kim, Young-Chul
    Kim, Kyu-Sik
    Oh, In-Jae
    Ban, Hee Jung
    Lee, Sung Yong
    Jang, Tae Won
    Shin, Kyeong-Cheol
    Lee, Gwan Ho
    Lce, Jae Chol
    Ryu, Jeong-Seon
    Jang, Seung Hoon
    Lee, Jeong Eun
    Kim, Sun Young
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S396 - S397
  • [37] Genotype-Guided Radiomics Signatures for Recurrence Prediction of Non-Small Cell Lung Cancer
    Aonpong, Panyanat
    Iwamoto, Yutaro
    Han, Xian-Hua
    Lin, Lanfen
    Chen, Yen-Wei
    IEEE ACCESS, 2021, 9 : 90244 - 90254
  • [38] Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
    Tang, Yong
    Qiao, Guibin
    Xu, Enwu
    Xuan, Yiwen
    Liao, Ming
    Yin, Guilin
    ONCOTARGETS AND THERAPY, 2017, 10 : 4527 - 4534
  • [39] FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer
    Kirienko, Margarita
    Gallivanone, Francesca
    Sollini, Martina
    Veronesi, Giulia
    Voulaz, Emanuele
    Antunovic, Lidjia
    Leonardi, Lorenzo
    Testanera, Giorgio
    Castiglioni, Isabella
    Chiti, Arturo
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2017, 22 : 1713 - 1723
  • [40] Molecular characteristics of non-small cell lung cancer
    Nacht, M
    Dracheva, T
    Gao, YH
    Fujii, T
    Chen, YD
    Player, A
    Akmaev, V
    Cook, B
    Dufault, M
    Zhang, M
    Zhang, W
    Guo, MZ
    Curran, J
    Han, S
    Sidransky, D
    Buetow, K
    Madden, SL
    Jen, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (26) : 15203 - 15208